MDHearing VoltMax vs RxEars Rxi

The MDHearing VoltMax is a behind-the-ear OTC hearing aid priced at $699, earning a B grade with a SoundScore of 3.0/5 in our lab testing. This places it in the lower tier of the OTC hearing aid category, ranking 62nd out of 65 devices tested. In our testing, the VoltMax delivered mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—above the category average by 0.46 points. This means users can expect stable performance without whistling or squealing during typical daily activities. However, speech clarity proved challenging, with speech-in-quiet scoring 1.9/5 (0.93 points below category average) and speech-in-noise at 1.0/5 (0.48 points below average). Own-voice comfort measured 2.4/5, slightly below the category norm. A significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average. Users who prioritize phone streaming for calls or media should consider alternatives. The device features rechargeable batteries, offering convenience over disposable options. At this price point, several competitors deliver substantially stronger overall performance. The VoltMax may appeal to budget-conscious consumers who primarily need basic amplification with reliable feedback control and don't require streaming capabilities. Those seeking better speech clarity or music streaming should explore higher-scoring options in this price range.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.